Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$43.67M
4 trades · 1 insiders
Net · 90d
$-43.67M
Insiders on file
22
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Fitzpatrick Jennifer | Chief Legal Officer | 21 | $0 | $1.45M | 2026-09-17 |
| McKee Charlotte | Chief Medical Officer | 10 | $0 | $0 | 2026-09-17 |
| Ridloff Elena | CFO and CBO | 17 | $0 | $1.97M | 2026-09-17 |
| Cloonan Michael | President & CEO, Director | 46 | $0 | $6.33M | 2026-09-17 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 44 | $20.25M | $49.17M | 2026-09-17 |
| OrbiMed Capital GP VIII LLC | Director | 11 | $9.90M | $6.80M | 2026-07-07 |
| Thompson Peter A. | Director | 26 | $9.90M | $55.67M | 2026-07-07 |
| ORBIMED ADVISORS LLC | Director | 13 | $0 | $48.87M | 2026-06-30 |
| Ruddy Marcella K. | Director | 3 | $0 | $0 | 2026-06-17 |
| RA Capital Nexus Fund III, L.P. | Director | 9 | $0 | $14.76M | 2026-06-17 |
| Fleming Harold Edward | Director | 2 | $0 | $0 | 2026-06-17 |
| Viney Joanne L. | Director | 3 | $0 | $0 | 2026-06-17 |
| Resnick Joshua | Director | 2 | $0 | $0 | 2026-06-17 |
| Stelzer Laurie | Director | 2 | $0 | $0 | 2026-06-17 |
| Booth Bruce | Director | 60 | $1.08M | $22.09M | 2026-06-17 |
| Clancy Paul J | Director | 2 | $0 | $0 | 2026-06-17 |
| WINKELRIED JON | 10% Owner | 1 | $0 | $10.00M | 2026-01-22 |
| Beer Caroline Stark | Chief Business Officer | 2 | $0 | $0 | 2026-01-02 |
| Kolchinsky Peter | Director, 10% Owner | 13 | $0 | $1.20M | 2025-11-21 |
| COULTER JAMES G | 10% Owner | 1 | $950.4K | $0 | 2025-06-27 |
| TPG GP A, LLC | 10% Owner | 6 | $20.25M | $0 | 2025-02-10 |
| Atlas Venture Fund XI, L.P. | 10% Owner | 8 | $1.08M | $0 | 2025-02-10 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cloonan Michael | President & CEO | D To issuer deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 0 | SEC↗ |
| Cloonan Michael | President & CEO | A Award deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 436,100 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | A Award deriv | 2026-09-17 | 2026-09-18 | 103,140 | — | $0 | 103,140 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | D To issuer deriv | 2026-09-17 | 2026-09-18 | 103,140 | — | $0 | 0 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | D To issuer deriv | 2026-09-17 | 2026-09-18 | 155,700 | — | $0 | 0 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | A Award deriv | 2026-09-17 | 2026-09-18 | 155,700 | — | $0 | 155,700 | SEC↗ |
| Ridloff Elena | CFO and CBO | D To issuer deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 0 | SEC↗ |
| Ridloff Elena | CFO and CBO | A Award deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 165,440 | SEC↗ |
| Cloonan Michael | President & CEO | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 765,393 | SEC↗ |
| Cloonan Michael | President & CEO | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 656,368 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | A Award | 2026-09-17 | 2026-09-18 | 28,133 | — | $0 | 28,133 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | A Award | 2026-09-17 | 2026-09-18 | 28,132 | — | $0 | 56,265 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | A Award | 2026-09-17 | 2026-09-18 | 50,000 | — | $0 | 78,415 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | A Award | 2026-09-17 | 2026-09-18 | 50,000 | — | $0 | 128,415 | SEC↗ |
| Ridloff Elena | CFO and CBO | A Award | 2026-09-17 | 2026-09-18 | 47,269 | — | $0 | 85,801 | SEC↗ |
| Ridloff Elena | CFO and CBO | A Award | 2026-09-17 | 2026-09-18 | 47,268 | — | $0 | 133,069 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| Ridloff Elena | CFO and CBO | D To issuer deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 0 | SEC↗ |
| Ridloff Elena | CFO and CBO | A Award deriv | 2026-09-17 | 2026-09-18 | 165,440 | — | $0 | 165,440 | SEC↗ |
| Ridloff Elena | CFO and CBO | A Award | 2026-09-17 | 2026-09-18 | 47,268 | — | $0 | 133,069 | SEC↗ |
| Ridloff Elena | CFO and CBO | A Award | 2026-09-17 | 2026-09-18 | 47,269 | — | $0 | 85,801 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | D To issuer deriv | 2026-09-17 | 2026-09-18 | 155,700 | — | $0 | 0 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | A Award deriv | 2026-09-17 | 2026-09-18 | 155,700 | — | $0 | 155,700 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | A Award | 2026-09-17 | 2026-09-18 | 50,000 | — | $0 | 128,415 | SEC↗ |
| McKee Charlotte | CMO and Head of R&D | A Award | 2026-09-17 | 2026-09-18 | 50,000 | — | $0 | 78,415 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | D To issuer deriv | 2026-09-17 | 2026-09-18 | 103,140 | — | $0 | 0 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | A Award deriv | 2026-09-17 | 2026-09-18 | 103,140 | — | $0 | 103,140 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | A Award | 2026-09-17 | 2026-09-18 | 28,132 | — | $0 | 56,265 | SEC↗ |
| Fitzpatrick Jennifer | CLO and Head of Program Mgmt | A Award | 2026-09-17 | 2026-09-18 | 28,133 | — | $0 | 28,133 | SEC↗ |
| Cloonan Michael | President & CEO, Director | D To issuer deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 0 | SEC↗ |
| Cloonan Michael | President & CEO, Director | A Award deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 436,100 | SEC↗ |
| Cloonan Michael | President & CEO, Director | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 765,393 | SEC↗ |
| Cloonan Michael | President & CEO, Director | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 656,368 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2026-07-07 | 2026-07-09 | 85,918 | $44.86 | $3.85M | 2,469,959 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-07-07 | 2026-07-09 | 85,918 | $44.86 | $3.85M | 2,469,959 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise deriv | 2026-07-06 | 2026-07-07 | 10,250 | — | $0 | 40,685 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | S Sale | 2026-07-06 | 2026-07-07 | 10,250 | $43.60 | $446.9K | 0 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise | 2026-07-06 | 2026-07-07 | 10,250 | $6.11 | $62.6K | 10,250 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-06-30 | 2026-07-02 | 115,844 | $45.50 | $5.27M | 2,555,877 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-06-30 | 2026-07-02 | 115,844 | $45.50 | $5.27M | 2,555,877 | SEC↗ |
| Booth Bruce | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Clancy Paul J | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Fleming Harold Edward | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Ruddy Marcella K. | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Viney Joanne L. | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-05-27 | 2026-05-29 | 101 | $44.49 | $4.5K | 2,671,721 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-05-27 | 2026-05-29 | 101 | $44.49 | $4.5K | 2,671,721 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-05-11 | 2026-05-11 | 184,639 | $46.22 | $8.53M | 2,671,822 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-05-11 | 2026-05-11 | 184,639 | $46.22 | $8.53M | 2,671,822 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-05-08 | 2026-05-11 | 59,767 | $44.58 | $2.66M | 2,856,461 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-05-08 | 2026-05-11 | 59,767 | $44.58 | $2.66M | 2,856,461 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-05-07 | 2026-05-11 | 48,546 | $44.61 | $2.17M | 2,916,228 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-05-07 | 2026-05-11 | 48,546 | $44.61 | $2.17M | 2,916,228 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-04-18 | 2026-04-21 | 2,948 | $44.52 | $131.2K | 2,964,774 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-04-18 | 2026-04-21 | 2,948 | $44.52 | $131.2K | 2,964,774 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-04-17 | 2026-04-21 | 52,397 | $44.68 | $2.34M | 2,967,722 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-04-17 | 2026-04-21 | 52,397 | $44.68 | $2.34M | 2,967,722 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-04-16 | 2026-04-16 | 226,906 | $45.34 | $10.29M | 3,020,119 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-04-16 | 2026-04-16 | 226,906 | $45.34 | $10.29M | 3,020,119 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-04-15 | 2026-04-16 | 235,863 | $44.64 | $10.53M | 3,247,025 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-04-15 | 2026-04-16 | 235,863 | $44.64 | $10.53M | 3,247,025 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2026-04-14 | 2026-04-16 | 47,814 | $44.51 | $2.13M | 3,482,888 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-04-14 | 2026-04-16 | 47,814 | $44.51 | $2.13M | 3,482,888 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise deriv | 2026-03-05 | 2026-03-06 | 10,250 | — | $0 | 50,935 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise | 2026-03-05 | 2026-03-06 | 10,250 | $6.11 | $62.6K | 10,250 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | S Sale | 2026-03-05 | 2026-03-06 | 10,250 | $33.86 | $347.1K | 0 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2026-02-03 | 2026-02-04 | 29,063 | $44.58 | $1.30M | 3,530,702 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-02-03 | 2026-02-04 | 29,063 | $44.58 | $1.30M | 3,530,702 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2026-02-02 | 2026-02-04 | 1,890 | $44.57 | $84.2K | 3,559,765 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2026-02-02 | 2026-02-04 | 1,890 | $44.57 | $84.2K | 3,559,765 | SEC↗ |
| WINKELRIED JON | 10% Owner | S Sale | 2026-01-22 | 2026-01-26 | 250,000 | $40.00 | $10.00M | 6,494,962 | SEC↗ |
| Ridloff Elena | CFO | A Award deriv | 2026-01-02 | 2026-01-06 | 165,440 | — | $0 | 165,440 | SEC↗ |
| Beer Caroline Stark | Chief Business Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 139,340 | — | $0 | 139,340 | SEC↗ |
| Cloonan Michael | President & CEO | A Award deriv | 2026-01-02 | 2026-01-06 | 436,100 | — | $0 | 436,100 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 103,140 | — | $0 | 103,140 | SEC↗ |
| McKee Charlotte | Chief Medical Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 155,700 | — | $0 | 155,700 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-12-24 | 2025-12-29 | 33,356 | $44.55 | $1.49M | 3,561,655 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2025-12-24 | 2025-12-29 | 33,356 | $44.55 | $1.49M | 3,561,655 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-12-19 | 2025-12-19 | 875 | $44.49 | $38.9K | 3,595,011 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2025-12-19 | 2025-12-19 | 875 | $44.49 | $38.9K | 3,595,011 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-12-18 | 2025-12-19 | 100 | $44.49 | $4.4K | 3,595,886 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2025-12-18 | 2025-12-19 | 100 | $44.49 | $4.4K | 3,595,886 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-12-17 | 2025-12-19 | 900 | $44.50 | $40.0K | 3,595,986 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | S Sale | 2025-12-17 | 2025-12-19 | 900 | $44.50 | $40.0K | 3,595,986 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise deriv | 2025-12-05 | 2025-12-09 | 10,250 | — | $0 | 61,185 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise | 2025-12-05 | 2025-12-09 | 10,250 | $6.11 | $62.6K | 10,250 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | S Sale | 2025-12-05 | 2025-12-09 | 10,250 | $40.52 | $415.3K | 0 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-11-26 | 2025-11-26 | 1,600 | $44.49 | $71.2K | 3,596,886 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2025-11-26 | 2025-11-26 | 1,600 | $44.49 | $71.2K | 3,596,886 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-11-25 | 2025-11-26 | 11,890 | $44.60 | $530.3K | 3,598,486 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2025-11-25 | 2025-11-26 | 11,890 | $44.60 | $530.3K | 3,598,486 | SEC↗ |
| Thompson Peter A. | Director | S Sale | 2025-11-24 | 2025-11-26 | 94,583 | $44.54 | $4.21M | 3,610,376 | SEC↗ |
| ORBIMED ADVISORS LLC | Director | S Sale | 2025-11-24 | 2025-11-26 | 94,583 | $44.54 | $4.21M | 3,610,376 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-21 | 2025-11-24 | 6,440 | $39.50 | $254.4K | 2,198,082 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-21 | 2025-11-24 | 9,924 | $39.50 | $392.0K | 650,307 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-21 | 2025-11-24 | 1,210 | $39.50 | $47.8K | 6,897,623 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-21 | 2025-11-24 | 7,609 | $39.50 | $300.6K | 159,033 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 788 | $40.50 | $31.9K | 660,231 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 604 | $40.50 | $24.5K | 166,642 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 512 | $40.50 | $20.7K | 2,204,522 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 96 | $40.50 | $3.9K | 6,898,833 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 947 | $39.89 | $37.8K | 167,246 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 801 | $39.89 | $32.0K | 2,205,034 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 1,235 | $39.89 | $49.3K | 661,019 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-11-20 | 2025-11-24 | 150 | $39.89 | $6.0K | 6,898,929 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 2,276 | $40.01 | $91.1K | 6,899,081 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 18,684 | $40.01 | $747.5K | 662,266 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 12,126 | $40.01 | $485.2K | 2,205,843 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 14,325 | $40.01 | $573.1K | 168,202 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 2 | $40.61 | $81 | 6,899,079 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 12 | $40.61 | $487 | 662,254 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 8 | $40.61 | $325 | 2,205,835 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-19 | 2025-11-19 | 9 | $40.61 | $365 | 168,193 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-18 | 2025-11-19 | 2,092 | $39.57 | $82.8K | 182,527 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-18 | 2025-11-19 | 332 | $39.57 | $13.1K | 6,901,357 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-18 | 2025-11-19 | 2,728 | $39.57 | $107.9K | 680,950 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-18 | 2025-11-19 | 1,770 | $39.57 | $70.0K | 2,217,969 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 2,182 | $40.20 | $87.7K | 6,903,443 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 17,913 | $40.20 | $720.1K | 698,075 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 11,626 | $40.20 | $467.4K | 2,229,082 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 13,734 | $40.20 | $552.1K | 195,657 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 1,701 | $41.05 | $69.8K | 6,901,742 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 13,964 | $41.05 | $573.2K | 684,111 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 9,063 | $41.05 | $372.0K | 2,220,019 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 10,707 | $41.05 | $439.5K | 184,950 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 331 | $42.10 | $13.9K | 184,619 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 280 | $42.10 | $11.8K | 2,219,739 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 433 | $42.10 | $18.2K | 683,678 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-11-17 | 2025-11-19 | 53 | $42.10 | $2.2K | 6,901,689 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-28 | 2025-10-28 | 31,392 | $39.58 | $1.24M | 715,988 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-28 | 2025-10-28 | 17,118 | $39.58 | $677.5K | 2,240,708 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-28 | 2025-10-28 | 10,476 | $39.58 | $414.6K | 209,391 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-28 | 2025-10-28 | 3,624 | $39.58 | $143.4K | 6,905,625 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-24 | 2025-10-28 | 14,116 | $39.50 | $557.6K | 6,909,249 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-24 | 2025-10-28 | 107,941 | $39.50 | $4.26M | 219,867 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-24 | 2025-10-28 | 122,271 | $39.50 | $4.83M | 747,380 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | S Sale | 2025-10-24 | 2025-10-28 | 66,672 | $39.50 | $2.63M | 2,257,826 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-21 | 2025-10-22 | 13,324 | — | $0 | 139,618 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-21 | 2025-10-22 | 30,049 | — | $0 | 109,569 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-21 | 2025-10-22 | 33,532 | — | $0 | 53,142 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-21 | 2025-10-22 | 22,895 | — | $0 | 86,674 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 22,339 | $32.69 | $730.3K | 2,360,156 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 4,688 | $32.69 | $153.3K | 697,297 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 19,948 | $33.87 | $675.6K | 2,340,208 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 4,187 | $33.87 | $141.8K | 693,110 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 5,763 | $34.91 | $201.2K | 2,334,445 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 1,210 | $34.91 | $42.2K | 691,900 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 25,327 | $35.69 | $903.9K | 2,309,118 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 5,316 | $35.69 | $189.7K | 686,584 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 17 | $36.42 | $619 | 686,567 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-21 | 2025-10-21 | 83 | $36.42 | $3.0K | 2,309,035 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-21 | 2025-10-22 | 30,049 | $6.11 | $183.6K | 577,392 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-21 | 2025-10-22 | 13,324 | $34.44 | $458.9K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-21 | 2025-10-22 | 13,324 | $6.11 | $81.4K | 560,667 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-21 | 2025-10-22 | 33,532 | $37.31 | $1.25M | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-21 | 2025-10-22 | 33,532 | $6.11 | $204.9K | 580,875 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-21 | 2025-10-22 | 22,895 | $36.60 | $838.0K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-21 | 2025-10-22 | 22,895 | $6.11 | $139.9K | 570,238 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-21 | 2025-10-22 | 30,049 | $35.63 | $1.07M | 547,343 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-20 | 2025-10-20 | 20,485 | $31.79 | $651.2K | 2,408,283 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-20 | 2025-10-20 | 4,300 | $31.79 | $136.7K | 707,397 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-20 | 2025-10-20 | 25,788 | $32.33 | $833.7K | 2,382,495 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-20 | 2025-10-20 | 5,412 | $32.33 | $175.0K | 701,985 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-17 | 2025-10-20 | 248 | $33.47 | $8.3K | 2,428,768 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-17 | 2025-10-20 | 4,503 | $32.71 | $147.3K | 711,749 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-17 | 2025-10-20 | 21,451 | $32.71 | $701.7K | 2,429,016 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-17 | 2025-10-20 | 6,049 | $32.10 | $194.2K | 716,252 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-17 | 2025-10-20 | 28,821 | $32.10 | $925.2K | 2,450,467 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-17 | 2025-10-20 | 52 | $33.47 | $1.7K | 711,697 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-16 | 2025-10-17 | 200 | — | $0 | 152,942 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-16 | 2025-10-17 | 10,225 | — | $0 | 153,142 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-16 | 2025-10-17 | 200 | $6.11 | $1.2K | 547,543 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-16 | 2025-10-17 | 200 | $34.00 | $6.8K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-16 | 2025-10-17 | 10,225 | $31.46 | $321.7K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-16 | 2025-10-17 | 10,225 | $6.11 | $62.5K | 557,568 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 12,888 | $33.38 | $430.2K | 2,479,288 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 8,596 | $30.15 | $259.2K | 2,610,589 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 1,804 | $30.15 | $54.4K | 749,860 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 45,117 | $31.69 | $1.43M | 2,565,472 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 9,470 | $31.69 | $300.1K | 740,390 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 73,296 | $32.84 | $2.41M | 2,492,176 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 15,384 | $32.84 | $505.2K | 725,006 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-16 | 2025-10-20 | 2,705 | $33.38 | $90.3K | 722,301 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-10-15 | 2025-10-17 | 14,775 | — | $0 | 163,367 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-15 | 2025-10-15 | 65,726 | $30.37 | $2.00M | 2,649,217 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-15 | 2025-10-15 | 13,795 | $30.37 | $419.0K | 757,967 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-15 | 2025-10-15 | 30,032 | $31.12 | $934.6K | 2,619,185 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-15 | 2025-10-15 | 6,303 | $31.12 | $196.1K | 751,664 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-10-15 | 2025-10-17 | 14,775 | $6.11 | $90.3K | 562,118 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-10-15 | 2025-10-17 | 14,775 | $31.11 | $459.7K | 547,343 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-14 | 2025-10-15 | 105 | $29.95 | $3.1K | 771,762 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-14 | 2025-10-15 | 501 | $29.95 | $15.0K | 2,714,943 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-13 | 2025-10-15 | 857 | $31.03 | $26.6K | 771,867 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-13 | 2025-10-15 | 4,082 | $31.03 | $126.7K | 2,715,444 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-13 | 2025-10-15 | 9,245 | $30.32 | $280.3K | 772,724 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-13 | 2025-10-15 | 44,048 | $30.32 | $1.34M | 2,719,526 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-10 | 2025-10-15 | 3,511 | $29.98 | $105.3K | 781,969 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-10 | 2025-10-15 | 16,727 | $29.98 | $501.5K | 2,763,574 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-06 | 2025-10-07 | 9,753 | $29.95 | $292.1K | 2,780,301 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-06 | 2025-10-07 | 2,047 | $29.95 | $61.3K | 785,480 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-03 | 2025-10-07 | 6,548 | $30.00 | $196.4K | 787,527 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-03 | 2025-10-07 | 31,198 | $30.00 | $935.9K | 2,790,054 | SEC↗ |
| Beer Caroline Stark | Chief Business Officer | A Award deriv | 2025-10-01 | 2025-10-03 | 255,000 | — | $0 | 255,000 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-01 | 2025-10-01 | 165 | $29.95 | $4.9K | 2,821,252 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-10-01 | 2025-10-01 | 35 | $29.95 | $1.0K | 794,075 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-09-30 | 2025-10-01 | 2,149 | $30.06 | $64.6K | 794,110 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-09-30 | 2025-10-01 | 10,239 | $30.06 | $307.8K | 2,821,417 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-09-29 | 2025-10-01 | 54,637 | $30.09 | $1.64M | 2,831,656 | SEC↗ |
| Booth Bruce | Director | S Sale | 2025-09-29 | 2025-10-01 | 11,468 | $30.09 | $345.1K | 796,259 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-09-29 | 2025-09-30 | 7,793 | — | $0 | 178,142 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-09-29 | 2025-09-30 | 7,793 | $29.70 | $231.5K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-09-29 | 2025-09-30 | 7,793 | $6.11 | $47.6K | 555,136 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-09-26 | 2025-09-30 | 17,207 | — | $0 | 185,935 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-09-26 | 2025-09-30 | 17,207 | $6.11 | $105.1K | 564,550 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-09-26 | 2025-09-30 | 17,207 | $28.85 | $496.4K | 547,343 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise deriv | 2025-09-04 | 2025-09-05 | 10,250 | — | $0 | 71,435 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | M Exercise | 2025-09-04 | 2025-09-05 | 10,250 | $6.11 | $62.6K | 10,250 | SEC↗ |
| Fitzpatrick Jennifer | Chief Legal Officer | S Sale | 2025-09-04 | 2025-09-05 | 10,250 | $23.12 | $237.0K | 0 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-09-02 | 2025-09-03 | 8,836 | $25.08 | $221.6K | 38,532 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-08-29 | 2025-09-03 | 748 | $25.18 | $18.8K | 47,368 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-08-28 | 2025-08-28 | 16,098 | $25.97 | $418.1K | 48,116 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-08-27 | 2025-08-28 | 7,426 | — | $0 | 203,142 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-08-27 | 2025-08-28 | 3,618 | $25.10 | $90.8K | 64,214 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-08-27 | 2025-08-28 | 7,426 | $25.01 | $185.7K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-08-27 | 2025-08-28 | 7,426 | $6.11 | $45.4K | 554,769 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-08-26 | 2025-08-28 | 17,574 | — | $0 | 210,568 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-08-26 | 2025-08-28 | 3,700 | $25.13 | $93.0K | 67,832 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-08-26 | 2025-08-28 | 17,574 | $6.11 | $107.4K | 564,917 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-08-26 | 2025-08-28 | 17,574 | $24.96 | $438.6K | 547,343 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise deriv | 2025-08-20 | 2025-08-21 | 25,000 | — | $0 | 228,142 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-08-20 | 2025-08-21 | 17,500 | $22.69 | $397.1K | 71,532 | SEC↗ |
| Cloonan Michael | President & CEO | M Exercise | 2025-08-20 | 2025-08-21 | 25,000 | $6.11 | $152.8K | 572,343 | SEC↗ |
| Cloonan Michael | President & CEO | S Sale | 2025-08-20 | 2025-08-21 | 25,000 | $22.75 | $568.8K | 547,343 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | S Sale | 2025-08-19 | 2025-08-21 | 34,500 | $21.08 | $727.3K | 89,032 | SEC↗ |
| COULTER JAMES G | 10% Owner | P Buy | 2025-06-27 | 2025-07-01 | 60,000 | $15.84 | $950.4K | 6,744,962 | SEC↗ |
| Booth Bruce | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Clancy Paul J | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Fleming Harold Edward | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Ruddy Marcella K. | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Thompson Peter A. | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Viney Joanne L. | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,051,051 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,806,317 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,298,332 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 61,463 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,092,504 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,560,951 | — | $0 | 0 | SEC↗ |
| Thompson Peter A. | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,048,760 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,298,332 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,051,051 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,092,504 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 61,463 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,806,317 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,560,951 | — | $0 | 0 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,048,760 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,155,469 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 4,364,874 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 124,908 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 923,773 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,091,219 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 451,580 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,229,830 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 819,153 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 319,069 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-10 | 138,054 | — | $0 | 0 | SEC↗ |
| TPG GP A, LLC | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-12 | 1,765,541 | — | $0 | 0 | SEC↗ |
| TPG GP A, LLC | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-12 | 1,806,318 | — | $0 | 0 | SEC↗ |
| TPG GP A, LLC | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-12 | 2,275,528 | — | $0 | 0 | SEC↗ |
| TPG GP A, LLC | 10% Owner | C Conversion deriv | 2025-02-10 | 2025-02-12 | 1,276,276 | — | $0 | 0 | SEC↗ |
| Booth Bruce | Director | C Conversion | 2025-02-10 | 2025-02-10 | 2,886,293 | — | $0 | 2,886,293 | SEC↗ |
| Booth Bruce | Director | C Conversion | 2025-02-10 | 2025-02-10 | 747,727 | — | $0 | 747,727 | SEC↗ |
| Booth Bruce | Director | P Buy | 2025-02-10 | 2025-02-10 | 60,000 | $18.00 | $1.08M | 807,727 | SEC↗ |
| Thompson Peter A. | Director | C Conversion | 2025-02-10 | 2025-02-10 | 3,154,959 | — | $0 | 3,154,959 | SEC↗ |
| Thompson Peter A. | Director | P Buy | 2025-02-10 | 2025-02-10 | 550,000 | $18.00 | $9.90M | 3,704,959 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion | 2025-02-10 | 2025-02-10 | 2,886,293 | — | $0 | 2,886,293 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | C Conversion | 2025-02-10 | 2025-02-10 | 747,727 | — | $0 | 747,727 | SEC↗ |
| Atlas Venture Fund XI, L.P. | 10% Owner | P Buy | 2025-02-10 | 2025-02-10 | 60,000 | $18.00 | $1.08M | 807,727 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | P Buy | 2025-02-10 | 2025-02-10 | 550,000 | $18.00 | $9.90M | 3,704,959 | SEC↗ |
| OrbiMed Capital GP VIII LLC | Director | C Conversion | 2025-02-10 | 2025-02-10 | 3,154,959 | — | $0 | 3,154,959 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | P Buy | 2025-02-10 | 2025-02-10 | 102,414 | $18.00 | $1.84M | 2,324,498 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | P Buy | 2025-02-10 | 2025-02-10 | 1,022,586 | $18.00 | $18.41M | 6,923,365 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion | 2025-02-10 | 2025-02-10 | 179,975 | — | $0 | 327,808 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion | 2025-02-10 | 2025-02-10 | 2,222,084 | — | $0 | 2,222,084 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion | 2025-02-10 | 2025-02-10 | 5,021,990 | — | $0 | 5,900,779 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | C Conversion | 2025-02-10 | 2025-02-10 | 527,444 | — | $0 | 869,651 | SEC↗ |
| TPG GP A, LLC | 10% Owner | P Buy | 2025-02-10 | 2025-02-12 | 1,125,000 | $18.00 | $20.25M | 6,684,962 | SEC↗ |
| TPG GP A, LLC | 10% Owner | C Conversion | 2025-02-10 | 2025-02-12 | 4,875,547 | — | $0 | 5,559,962 | SEC↗ |
| McKee Charlotte | Chief Medical Officer | A Award deriv | 2025-02-06 | 2025-02-10 | 148,536 | — | $0 | 148,536 | SEC↗ |
| Cloonan Michael | President & CEO | A Award deriv | 2025-02-06 | 2025-02-10 | 450,252 | — | $0 | 450,252 | SEC↗ |
| Ridloff Elena | CFO & Head of Corp. Dev. | A Award deriv | 2025-02-06 | 2025-02-10 | 157,820 | — | $0 | 157,820 | SEC↗ |